RASPELD to Perform High-End Screening in an Academic Environment toward the Development of Cancer Therapeutics.

Abstract excerpt

The identification of compounds for dissecting biological functions and the development of novel drug molecules are central tasks that often require screening campaigns. However, the required architecture is cost- and time-intensive. Herein we describe the devices and technologies that comprise a Robotics-Assisted Screening Platform for Efficient Ligand Discovery (RASPELD), which we set up in an academic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biological Assay
• Share to Drug Evaluation, Preclinical